Georgia CTSA COVID-19 Response


Georgia CTSA is taking an active role in monitoring the COVID-19 pandemic and sharing important news updates. We are continuously collecting and sharing news of how our trainees, scholars, investigators, faculty, and staff are responding to the COVID-19 virus. Learn more about what we are doing and resources available to you.

Featured News

NIH COVID-19 Communities Responding Together

Download resources for use in talking to your communities about COVID-19, the vaccines under development, how they are developed, and the importance of being included in research studies. Review information on educating and recruiting clinical trial participants and ensuring diversity in clinical trials. Use the link below to bookmark these resources and return often for new resources to help you engage community organizations and individuals.

NIH Delivering New COVID-19 Tests Validated by Georgia CTSA Leaders

The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative has awarded contracts to seven biomedical diagnostic companies whose innovative technologies will increase the availability of COVID-19 tests by millions per week as early as September 2020. While expanding the nation’s testing capacity, these testing technologies use different methods including more convenient sampling, such as saliva testing, while some technologies provide results within minutes at the point of care including schools, offices, and nursing homes. Two of Georgia CTSA’s leaders head up the NIBIB-funded Atlanta Center Microsystems Engineered Point of Care Technologies (ACME POCT) which was selected by the NIH, along with their institutions - Emory, Georgia Tech, and Children’s Healthcare of Atlanta - to test and validate some of the most promising technologies for COVID-19 diagnostic tests.

Participants Needed for COVID-19 Vaccine and Therapeutic Trials

Adults 18 and older, from all races and ethnicities, are needed to participate in COVID-19 trials. Please spread the word to help recruit minorities, especially for vaccine trials. Register Register online or contact Hope Clinic (Decatur), 404-712-1371; Emory Children’s Center (main campus), 404-727-4044; or Ponce CRS (Downtown/Grady), 770-286-3327.

Georgia CTSA Leads Serosurvey for CDC and FEMA COVID-19 Responders

Georgia CTSA and Emory University including the Emory Medical Laboratory assisted the Centers for Disease Control and Prevention (CDC) and the Federal Emergency Management Agency (FEMA) in conducting a serosurvey to assess the presence of antibodies to SARS-CoV-2 among their workforce who are participating in the COVID-19 response. Georgia CTSA completed more than 1,200 blood draws for a COVID-19 serology (antibody) testing for CDC first responders and Emory Healthcare staff for the COPE study. Additionally, Georgia CTSA helped test 476 blood samples from FEMA and HHS first-line responders stationed in Washington, DC for a total of just under 1,700 tests.

Georgia CTSA Investigators Encouraged by COVID-19 Vaccine Trial

Georgia CTSA investigators Evan Anderson, MD, and Nadine Rouphael, MD, co-authored results published in NEJM reporting a robust anti–SARS-CoV-2 immune response in all study participants during the investigational mRNA-1273 vaccine phase 1 trial. Anderson is the principal investigator and Rouphael is the contact principal investigator for the trial at Emory. The phase 3 efficacy trial is scheduled to begin on July 23.

NIH Launches National COVID Cohort Collaborative

The NIH has launched a centralized, secure enclave to store and study vast amounts of medical record data from people diagnosed with coronavirus disease across the country. It is part of an effort, called the National COVID Cohort Collaborative (N3C), to help scientists analyze these data to understand the disease and develop treatments. This effort aims to transform clinical information into knowledge urgently needed to study COVID-19.

Georgia CTSA Leaders to Begin Phase 1 Validation for National COVID-19 Tests

Two of Georgia CTSA's leaders head up the NIBIB-funded Atlanta Center Microsystems Engineered Point of Care Technologies (ACME POCT) which has been selected by the NIH, along with their institutions - Emory, Georgia Tech, and Children’s Healthcare of Atlanta - to test and validate some of the most promising technologies for COVID-19 diagnostic testing.

Former Georgia CTSA KL2 Scholar Helps Lead COVID-19 Research Efforts

As an accomplished research physician-scientist with several NIH R01 grants as Principal Investigator, Colleen Kelley MD, MPH, Associate Professor, Emory University School of Medicine, Division of Infectious Diseases, and Georgia Clinical & Translational Science Alliance (Georgia CTSA) former KL2 Scholar is actively involved in several research efforts around COVID-19 including ongoing clinical trials and related research activities.

Georgia CTSA CPTR Graduate's Anti-Inflammatory Drug Selected for International Phase 3 COVID-19 Trial

Christina Gavegnano, PhD, Assistant Professor, Emory University School of Medicine, and Georgia Clinical & Translational Science Alliance (Georgia CTSA) Certificate Program in Translational Research (CPTR) graduate, has been working with Baricitinib for the indication of HIV and shares the internationally-issued patent for use for viral infections. Baricitinib has been selected by the National Institutes of Health (NIH) for a multi-country phase 3 study for COVID-19 treatment.

COVID-19 Prevention Measures Advocated by Georgia CTSA MSCR Grad

Marybeth Sexton, MD, MSc, Assistant Professor, Emory University School of Medicine, member of the Serious Communicable Disease Unit team at Emory University Hospital and Georgia Clinical & Translational Science Alliance (Georgia CTSA) Master in Science in Clinical Research (MSCR) graduate, has been actively sharing COVID-19 prevention and protective strategies to limit the spread of COVID-19. Her current focus is on communicating the importance of social distancing during the pandemic.

Georgia CTSA MSCR Grad Helps Develop Best Practices for COVID ICU

Sara Auld, MD, MSc, Assistant Professor, Emory University School of Medicine and Rollins School of Public Health, and Georgia Clinical & Translational Science Alliance (Georgia CTSA) Master in Science in Clinical Research (MSCR) graduate, has helped her team develop best practices and guidelines for ICU patients at Emory University Hospital Midtown who have COVID-19.

Georgia CTSA Former Trainee Scales Up In-House COVID-19 Test

Paulina Rebolledo, MD, MSc, Assistant Professor, Emory University School of Medicine, Division of Infectious Diseases, Rollins School of Public Health, Hubert Department of Global Health and Georgia Clinical & Translational Science Alliance (Georgia CTSA) Master in Science in Clinical Research (MSCR) graduate, has worked with her team to scale up an in-house COVID-19 diagnostic test at Grady Memorial Hospital.

Former Georgia CTSA Trainee Helps Lead ICU Response to COVID-19

Annette Esper, MD, MSc, Associate Professor, Emory University School of Medicine, Division of Pulmonary and Critical Care Medicine, and Georgia Clinical & Translational Science Alliance (Georgia CTSA) Master in Science in Clinical Research (MSCR) graduate, is engaged with her team in Grady’s ICU in the ongoing battle against COVID-19. The team restructured their current intensive care units and deployment of those units. Since there are multiple ICUs at Grady, the team cohorted the COVID patients and designated a specific ICU a COVID ICU.

Georgia CTSA MSCR Graduates on Front Line of COVID-19 Battle

Jeffrey Collins, MD, MSc, Assistant Professor, and Russell Kempker, MD, MSc, Associate Professor, Emory University School of Medicine, Division of Infectious Diseases, NIH-funded physician-scientists, and Georgia Clinical & Translational Science Alliance (Georgia CTSA) Master in Science in Clinical Research (MSCR) graduates, are on the front lines of the battle against COVID-19. Collins and Kempker were both on Infectious Diseases clinical service at Grady Hospital when the SARS-CoV2 virus came to Atlanta and diagnosed the first patients seen at Grady with COVID-19.

Georgia CTSA Rapid Response Team Coordinates 48-Hour Approval for Treatment of Coronavirus Patient

Emory's first coronavirus patient began receiving infusion therapy as a result of Georgia CTSA's assistance in coordinating the approvals needed within 48 hours. Georgia CTSA's Navigator Team utilized the new Standard Operating Procedure (SOP) for its Rapid Response Team service to obtain fast-track approvals across the Emory system.

Georgia CTSA Leader Named to Georgia's Coronavirus Task Force

Georgia CTSA Clinical Research Centers (GCRCs) Director Colleen Kraft, MD, MSc, has been named to Georgia Governor Brian Kemp's Coronavirus Task Force. The 18-member task force of health, airport, school and emergency preparedness officials has been asked to identify the best way to prevent the spread of the coronavirus in Georgia.

Funding Opportunities

I3 Synergy Kaiser Permanente Georgia COVID-19 Collaboration Awards - Due October 13

We are soliciting research proposals in health services research focused on the collaborative efforts by Emory Healthcare and Kaiser Permanente Georgia in addressing the impact of COVID-19. Proposals must demonstrate immediacy and feasibility to execute in less than one year and have strong potential for external funding for a collaborative proposal. Areas for proposals include healthcare quality, access, safety, outcomes, and resource stewardship.

WHSC COVID-19 Center for Urgent Research Engagement (COVID-19 CURE) and Awards Program – Rolling Acceptance until December 15

The Woodruff Health Sciences Center (WHSC) announces the launch of the WHSC COVID-19 CENTER for URGENT RESEARCH ENGAGEMENT (COVID-19 CURE) and Awards Program, made possible by generous philanthropic support from the O. Wayne Rollins Foundation and the William Randolph Hearst Foundation. The CURE Center was created to facilitate high-impact science and discovery towards improved COVID-19 treatment and prevention research. The funds can be used to support new COVID-19 focused researchers, equipment/instrumentation, technical support, pilots and enhancing facilities for this work. In addition, COVID-19 CURE will act as a hub, facilitating and helping to prioritize Emory COVID-19 research activities. 

COVID-19 Resources and Guidance: Information You Need, When and Where You Need It

For up-to-date NIH COVID-19 information, including: Informational Videos; Proposal Submission & Award Management Resources; Human Subjects & Clinical Trials Guidance; Animal Welfare; Frequently Asked Questions regarding flexibilities for grantees and; Funding Opportunities, please visit the link below.

COVID-19 Funding Opportunities and Resources

With information and funding opportunities quickly evolving during this pandemic, we want to make sure our NCATS Consortium has the most up-to-date and readily available information. You can find the latest opportunities that NCATS is participating in by following this link.

Research Resources

NCATS Web Content on The National COVID Cohort Collaborative (N3C)

NCATS web content on the National COVID Cohort Collaborative (N3C) is now available including links to program resources, related funding opportunities, and frequently asked questions.

National COVID Cohort Collaborative (N3C)

The National Center for Data to Health and NCATS are leading the creation of a national, centralized, secure portal for COVID-19 clinical data. The cloud-based collaborative portal will allow for the development of machine learning and other informatics tools that require a large row-level dataset and will be overseen by a data access committee. This portal will provide additional assets needed to rapidly develop the analytics that clinical centers and physicians need now.

COVID-19 Collaboration Platform

The COVID-19 Collaboration Platform brings unassociated research teams working on the same clinical research questions together to share protocols, data, and evidence. COVID-19 Collaboration Platform offers support managing collaborations, including expedited and prioritized help from the Trial Innovation Network and SMART IRB to form multi-site trials; expert statistical advice for aggregated analyses, and free data storage and anonymization through vivli.org.

COVID-19 Resources and Guidance: Information You Need, When and Where You Need it

For up-to-date NIH COVID-19 information, including: Informational Videos; Proposal Submission & Award Management Resources; Human Subjects & Clinical Trials Guidance; Animal Welfare; Frequently Asked Questions regarding flexibilities for grantees and; Funding Opportunities, please visit the link.

DAR COVID-19 and Revised PPE Guidance

In response to new CDC guidance, the Division of Animal Resources will provide one face mask per person/week, one disposable yellow gown per person/week per room, and a storage container. This practice aligns with Emory Healthcare and aims to protect staff while conserving personal protective equipment (PPE). View the link below to learn more details on the revised PPE guidance.

Equipment Request for Emory COVID-19 Research Projects

Many Emory investigators are pursuing essential and critical research projects focused on the COVID-19 pandemic. If you have plans to collect or are currently collecting samples from COVID-19 patients, please respond with a brief description of your work and the type of sample (DNA, serum, PBMCs) you need. Providing essential platforms to support COVID-19 research is a high priority. Requests for new equipment to directly support COVID-19 research are being collected via email. Please send an email to Mike Zwick at mzwick@emory.edu.

Data Sharing COVID-19

We are a community of medical professionals, life scientists and data scientists on a quest to defeat COVID-19. To pitch in, join our discourse!

XSEDE's HPC-COVID19 Consortium: HPC Resources available to fight COVID-19

The COVID-19 HPC Consortium encompasses computing capabilities from some of the most powerful and advanced computers in the world. We hope to empower researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections. Consortium members manage a range of computing capabilities that span from small clusters to some of the very largest supercomputers in the world. Learn more about how to request access to resources of the COVID-19 HPC Consortium.

Community Resources

Participants Needed for COVID-19 Vaccine and Therapeutic Trials

Adults 18 and older, from all races and ethnicities, are needed to participate in COVID-19 trials. Please spread the word to help recruit minorities, especially for vaccine trials. Register at www.coronaviruspreventionnetwork.org. Or contact Hope Clinic (Decatur) vaccine@emory.edu, 404-712-1371; Emory Children’s Center (main campus) ecc.vaccine@emory.edu, 404-727-4044; or Ponce CRS (Downtown/Grady) atl.ponce.crs@emory.edu, 770-286-3327.

Special Webinar Events

Upcoming

Blue Sky Group: COVID–19 and Health Equality

October 27th, 2020 | 4:00 pm - 5:30 pm 

Previous Events and Webinar Sessions:

Blue Sky Groups

Special COVID Webinars